The treatment of Allergies & Meniere's Disease with vitamins

Allergies and Meniere's Disease: Mitamins custom make quality formulas for the treatment of Allergies & Meniere's Disease with vitamins. A Allergies & Meniere's Disease formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Allergies and Meniere's Disease

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Niacin
    50
    mg
    250%
    Vitamin B6
    50
    mg
    2500%
    Lactobacillus acidolphilus
    100
    mg
    *
    CoQ-10
    50
    mg
    *
    Lecithin
    50
    mg
    *
  • Amount Per Serving
    % DV
    MSM
    100
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    Betaine HCl
    50
    mg
    *
    Thymus
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Allergies and Meniere's Disease
Serving Size:4-5

Allergies and Meniere's Disease Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Aptivus(R) (tipranavir) Capsules Granted Full Approval By The U.S. FDA
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) granted full (traditional) approval of Aptivus(R) (tipranavir) capsules. The FDA granted accelerated approval to APTIVUS in June 2005; accelerated approval is a regulatory process that expedites the approval of therapies for serious or life-threatening illnesses.
Childhood Cancer Survivors Face Increased Sarcoma Risk (HealthDay)
Survivors of pediatric cancer face nine times the normal risk for developing a sarcoma at least five years after treatment for the initial cancer, a new study reveals.
This information concerning the support of Allergies and Meniere's Disease treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments